This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Limoneira (LMNR) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -57.89% and -1.51%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?
Chewy (CHWY) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Deleverage in SG&A expenses might have weighed on Chewy's (CHWY) bottom-line performance in fourth-quarter fiscal 2019.
Limoneira (LMNR) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Limoneira (LMNR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is a Beat in Store for ABM Industries' (ABM) Q1 Earnings?
by Zacks Equity Research
ABM Industries' (ABM) first-quarter fiscal 2020 revenues are likely to have benefited from organic growth.
Things to Note Ahead of Keurig Dr Pepper's (KDP) Q4 Earnings
by Zacks Equity Research
Keurig Dr Pepper's (KDP) fourth-quarter 2019 results are likely to reflect gains from acquisitions and positive effect of Allied Brands. However, unfavorable currency fluctuation remains a concern.
AB InBev (BUD) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
AB InBev's (BUD) Q4 results might reflect strength in global brands and the benefits of ongoing premiumization efforts. Soft beer demand and cost inflation are likely to have hurt performance.
Here's How FEMSA (FMX) is Placed Ahead of Earnings in Q4
by Zacks Equity Research
FEMSA's (FMX) Q4 results might reflect growth across all segments on strength across regions, robust pricing and revenue-management initiatives. Higher expenses might have hurt margins.
Limoneira (LMNR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 0.00% and 47.19%, respectively, for the quarter ended October 2019. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Archer Daniels (ADM) Stock Looks Going Into 2020
by Zacks Equity Research
Archer Daniels' (ADM) Readiness initiative and three strategic pillars - optimize, drive and growth - will likely drive performance in the next year.
Limoneira (LMNR) Reports Break-Even Earnings for Q3
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 100.00% and 11.15%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for September 4th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Analysts Estimate Limoneira (LMNR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agriculture Operations Outlook: Tariffs to Mar Organic Gains
by Rajani Lohia
The Zacks Agriculture - Operations industry should witness gains from wooing customers with organic solutions for crop production. Yet, tariff-related headwinds remain threats to top line.
Limoneira (LMNR) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 18.18% and -3.45%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Limoneira (LMNR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
US-China Trade Talks to Influence Agriculture Operations Outlook
by Rajani Lohia
The U.S. agriculture exports are widely impacted by the tariff war with China, the largest importer of U.S. soybeans. Nevertheless, initial U.S.-China trade talks bring hopes for the industry.
Archer Daniels' Cost Savings & Project Readiness Bode Well
by Zacks Equity Research
Archer Daniels (ADM) gains from its strategic initiatives such as cost savings, management of business portfolio and Project Readiness.
Limoneira (LMNR) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -83.33% and -6.08%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 9.09% and -11.84%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Limoneira (LMNR) Q4 Earnings Expected to Decline
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agriculture-Operations Industry Rides Wave of Organic Foods
by Zacks Equity Research
Increasing shift to organic production techniques to satisfy changing consumer preference should bolster demand for agri-based products.
Limoneira (LMNR) Q3 Earnings Miss Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -5.66% and 6.03%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brown-Forman Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Brown-Forman (BF.B) touches a 52-week high on the back of its robust strategies, including growth and expansion plans, solid brand portfolio along with an impressive surprise trend.